Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, et al
10-year follow-up of intensive glucose control in type 2 diabetes
In 1960, Dr Karl Eckbom added that it is so common and causes such suffering that it should be known to every physician
Tirzepatide, which acts on both GLP-1 and GIP receptors, can further lower blood sugar, promote weight loss, and improve lipid levels
The results of the present clinical trial study provided promising evidence that early supplementation with L-carnitine in first-ever diagnosed ischemic stroke patients improves their anthropometric status and prevents muscle wasting, rapid weight loss, and malnourishment or worsening during hospitalization